Accelerating drug development in pediatric cancer: a novel Phase I study design of venetoclax in relapsed/refractory malignancies

Future Oncology, Ahead of Print.


from Cancer via ola Kala on Inoreader https://ift.tt/2uwTs4r
via IFTTT